Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Nadroparin Atc B01Ab06 Obg For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8778724

EMD:Ref Document

Bid Value: Ref Document

228 Days Left

Open House Drug Discount Agreements Rasagiline Atc N04Bd02

Deadline: 05 Sep 2026

Germany

Ref. No.: 8778473

EMD:Ref Document

Bid Value: Ref Document

228 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8764279

EMD:Ref Document

Bid Value: Ref Document

345 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8751368

EMD:Ref Document

Bid Value: Ref Document

345 Days Left

Pkb Parachutes Ussoccom

Deadline: 11 Dec 2027

United States

Ref. No.: 8705097

EMD:Ref Document

Bid Value: Ref Document

690 Days Left

Drug Eluting Electrical Implant To Repair The Spinal Cord

Deadline: 30 Nov 2026

Spain

Ref. No.: 8675423

EMD:Ref Document

Bid Value: Ref Document

314 Days Left

Pharmaceutical Discount Agreements Pursuant To Section 130A Para 8 Sgb V Within The Framework Of Open House Procedures

Deadline: 07 Sep 2026

Germany

Ref. No.: 8660700

EMD:Ref Document

Bid Value: Ref Document

230 Days Left

Open House Discount Contracts 2024 11

Deadline: 31 Oct 2026

Germany

Ref. No.: 8612553

EMD:Ref Document

Bid Value: Ref Document

284 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8570586

EMD:Ref Document

Bid Value: Ref Document

345 Days Left

Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure

Deadline: 01 Sep 2026

Germany

Ref. No.: 8564108

EMD:Ref Document

Bid Value: Ref Document

224 Days Left

Open House Original Rebate Agreements 2024 09 Nintedanib Finished Medicinal Product Name Ofev R

Deadline: 31 Oct 2026

Germany

Ref. No.: 8552170

EMD:Ref Document

Bid Value: Ref Document

284 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8542116

EMD:Ref Document

Bid Value: Ref Document

345 Days Left

The First Non Clogging Continuous Flow Reactor Technology

Deadline: 28 Feb 2026

France

Ref. No.: 8503739

EMD:Ref Document

Bid Value: Ref Document

39 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Glyceryl Trinitrate Atc Code According To Who C01Da02

Deadline: 31 Oct 2026

Germany

Ref. No.: 8314020

EMD:Ref Document

Bid Value: Ref Document

284 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bosutinib

Deadline: 10 May 2026

Germany

Ref. No.: 8312368

EMD:Ref Document

Bid Value: Ref Document

110 Days Left

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

FREE Trial plan for all new users!